INTERVIEWS

Lucid News Apr 12, 2023

Will Ibogaine Fit into the Medicalized Psychedelic Landscape?

Much of what we know about ibogaine’s anti-addictive properties is substantiated by “a large number of uncontrolled and anecdotal case studies.”

Benzinga Apr 11, 2023

Bipartisan Letter Calls For Including Active Service Members In Psychedelic-Assisted Therapy Research

The letter aims to include language within the 2024 FY appropriations bill.

Double Blind Apr 10, 2023

New Bill Would Force DEA to Let Patients Use Psychedelics (and Cannabis)

Lawmakers want the DEA to clarify that the seriously ill can access psychedelics under “Right to Try” laws

MAPS Apr 5, 2023

MAPS Announces Positive Results from MDMA Phase 3B Trial

Interim results show improvements in PTSD symptom severity lasted at least six months after the last treatment session.

Lucid News Apr 5, 2023

California Bill to Decriminalize Some Psychedelics Advances Through the Legislature

Sponsored by Senator Scott Wiener, SB 58 would decriminalize the possession and use of some psychedelic substances in California.

Lucid News Apr 3, 2023

Vets Encourage Psychedelic Bipartisanship

It’s now standard practice for advocates, when briefing politicians and their staffs, to pair a vet who has a personal story of war trauma and psychedelic healing alongside a medical researcher who speaks authoritatively about scientific findings.

Double Blind Apr 3, 2023

The First Legal Magic Mushroom Farms Are Approved to Grow in Oregon

Shroom growers are among the first legal psilocybin businesses to be licensed in the state, which will allow guided journeys in the coming months.

Marijuana Moment Mar 31, 2023

Connecticut Lawmakers Approve Bill To Decriminalize Psilocybin In Joint Committee Vote

The measure would make possession of up to half an ounce of psychedelic mushrooms a civil infraction, punishable by a $150 fine.

Marijuana Moment Mar 30, 2023

Washington House Panel Amends Psilocybin Research Bill To Add Patient Access Provisions Back In

A House committee has inserted some therapeutic access provisions back into the legislation after the Senate had stripped it down to focus on research only.

Lucid News Mar 29, 2023

Psilocybin Therapies Attract Support in Illinois Legislature

A coalition behind Illinois’ proposed CURE Act is proposing the statewide legalization of psilocybin and psilocybin therapy sparked by collaboration between a state lawmaker and a local Psychedelic Society.

Green Market Report Mar 29, 2023

Massachusetts Republican Wants to Cap Potential MDMA Therapy Costs

Costs of the therapy are estimated at up to $15,000.

Lucid News Mar 26, 2023

It’s Survival of the Fittest among Psychedelic Start-Ups

The unusual level of uncertainty in financial systems will continue to present challenges for companies in the psychedelic sector.

Oregon Health Authority Mar 24, 2023

Oregon Issues the State’s First Psilocybin License

The manufacturer license was issued to Satori Farms.

Benzinga Mar 21, 2023

New Psychedelic Medicine PAC Will Lobby For Advancing Research In Congress

With the goal of raising $10 million in its first year, the new group is petitioning donors, including investors in the for-profit biotech space.

Lucid News Mar 21, 2023

Opinion: Are Psychedelics a New Paradigm or Business as Usual?

Very few of the current psychedelic pharmaceutical startups will survive, but most will perish.

Marijuana Moment Mar 20, 2023

Minnesota Lawmakers Take Up Bill To Create Psychedelics Task Force To Plan For Legalization

Under the bill, a Psychedelic Medicine Task Force would be established in order to “advise the legislature on the legal, medical, and policy issues associated with the legalization of psychedelic medicine in the state.”

Microdose Mar 20, 2023

Canadians Launch Petition to Legalize Psilocybin Therapy

The country is pushing forward on legalization. Could it work?

Double Blind Mar 19, 2023

Vermont Could Legalize Psychedelics and Decriminalize All Drugs

State lawmakers filed four major drug reform initiatives this month, but the progressive policies still face political obstacles.

Psychedelic Alpha Mar 16, 2023

Reunion Sues Mindset, Claims it Copied RE104

A lawsuit filed on behalf of psychedelic drug developer Reunion Neuroscience alleges that Mindset Pharma “knowingly copied” Reunion’s drug candidate.

Double Blind Mar 15, 2023

Ketamine Therapy and Virtual Reality Together? Welcome to the Future

A Texas-based ketamine center says this combo “takes [people] out of their own day-to-day mindset”